DK134742B - Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved. - Google Patents

Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved.

Info

Publication number
DK134742B
DK134742B DK17474AA DK17474A DK134742B DK 134742 B DK134742 B DK 134742B DK 17474A A DK17474A A DK 17474AA DK 17474 A DK17474 A DK 17474A DK 134742 B DK134742 B DK 134742B
Authority
DK
Denmark
Prior art keywords
stable
preparation
parenteral administration
solutions containing
administration suitable
Prior art date
Application number
DK17474AA
Other languages
Danish (da)
English (en)
Inventor
Gabor Szepesi
Takacsi Nagy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK134742B publication Critical patent/DK134742B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK17474AA 1973-01-15 1974-01-14 Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved. DK134742B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI496A HU166289B (en:Method) 1973-01-15 1973-01-15

Publications (1)

Publication Number Publication Date
DK134742B true DK134742B (da) 1977-01-10

Family

ID=11000913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17474AA DK134742B (da) 1973-01-15 1974-01-14 Fremgangsmåde til fremstilling af til parenteral indgivelse egnede, stabile, vandige opløsninger, der indeholder aminoketonderivater og vandigt medium til anvendelse herved.

Country Status (13)

Country Link
JP (1) JPS505521A (en:Method)
AT (1) AT332552B (en:Method)
AU (1) AU6354673A (en:Method)
BE (1) BE809693A (en:Method)
CS (1) CS172273B2 (en:Method)
DD (1) DD108460A5 (en:Method)
DE (1) DE2362337A1 (en:Method)
DK (1) DK134742B (en:Method)
FR (1) FR2213768B1 (en:Method)
GB (1) GB1440275A (en:Method)
HU (1) HU166289B (en:Method)
IL (1) IL43814A0 (en:Method)
NL (1) NL7317458A (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54125630A (en) * 1978-02-22 1979-09-29 Nippon Zoki Pharmaceutical Co Novel propanone derivative*its manufacture and medical composition containing it as active component

Also Published As

Publication number Publication date
AT332552B (de) 1976-10-11
CS172273B2 (en) 1976-12-29
ATA22374A (de) 1976-01-15
IL43814A0 (en) 1974-03-14
FR2213768B1 (en:Method) 1977-07-01
HU166289B (en:Method) 1975-02-28
NL7317458A (en:Method) 1974-07-17
BE809693A (fr) 1974-05-02
AU6354673A (en) 1975-06-12
DD108460A5 (en:Method) 1974-09-20
JPS505521A (en:Method) 1975-01-21
GB1440275A (en) 1976-06-23
FR2213768A1 (en:Method) 1974-08-09
DE2362337A1 (de) 1974-07-18

Similar Documents

Publication Publication Date Title
DK117587B (da) Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
DK138974B (da) Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DK138798B (da) Fremgangsmåde til fremstilling af optisk aktive 1,4-benzodiazepin-2-on-derivater.
DK135454B (da) Analogifremgangsmåde til fremstilling af 2,1,3-benzothiadiazolderivater.
SE7504451L (sv) Asymmetriska, halvgenomtrengliga membraner av polybens-1,3-oxazindioner-(2,3).
DK138492B (da) Fremgangsmåde til fremstilling af morphinanderivater.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
NO141655C (no) Konsentrert, flytende saapeopploesning
DK140696B (da) Funktionaliserede adeninderivater til anvendelse til fremstilling af makromolekylære adeninderivater.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK129079B (da) Fremgangsmåde til fremstilling af smagsmæssigt upåklagelige, fysisk stabile, klare, sirupsagtige, alkoholiske opløsninger, der indeholder organiske baser.
DK370875A (da) Fremgangsmade til fremstilling af insulin, insulin-analoge og -derivater
CH552043A (de) Stabile, konzentrierte loesungen basischer azofarbstoffe.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK138399B (da) Fremgangsmåde til fremstilling af purpuromycin og derivater deraf.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK139716B (da) Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.
DK139682B (da) Analogifremgangsmåde til fremstilling af eburnameninderivater.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK135943B (da) Fremgangsmåde til fremstilling af propanolaminderivater.
DK138389B (da) Analogifremgangsmåde til fremstilling af quinoxalin-1,4-dioxydderivater.
DK136652B (da) Fremgangsmåde til fremstilling af thieno-pyridinderivater.
DK129237B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater og salte deraf.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment